Oncolytics Biotech
ONCY
#9263
Rank
โ‚น9.03 B
Marketcap
โ‚น85.12
Share price
-4.78%
Change (1 day)
14.24%
Change (1 year)

Oncolytics Biotech (ONCY) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น0.79 Billion

According to Oncolytics Biotech 's latest financial reports the company has โ‚น0.79 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oncolytics Biotech - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น0.95 B-56.51%
2023-12-31โ‚น2.19 B11.81%
2022-12-31โ‚น1.95 B-18.67%
2021-12-31โ‚น2.40 B34.58%
2020-12-31โ‚น1.79 B131.81%
2019-12-31โ‚น0.77 B9.85%
2018-12-31โ‚น0.70 B16.99%
2017-12-31โ‚น0.60 B-15.83%
2016-12-31โ‚น0.71 B-42.83%
2015-12-31โ‚น1.24 B41.34%
2014-12-31โ‚น0.88 B-44.05%
2013-12-31โ‚น1.57 B34.75%
2012-12-31โ‚น1.17 B-35.32%
2011-12-31โ‚น1.81 B-5.76%
2010-12-31โ‚น1.92 B27.8%
2009-12-31โ‚น1.50 B186.76%
2008-12-31โ‚น0.52 B-47.09%
2007-12-31โ‚น0.99 B-5.57%
2006-12-31โ‚น1.05 B-32.74%
2005-12-31โ‚น1.56 B27.7%
2004-12-31โ‚น1.22 B67.91%
2003-12-31โ‚น0.72 B188.37%
2002-12-31โ‚น0.25 B-44.29%
2001-12-31โ‚น0.45 B-17.39%
2000-12-31โ‚น0.54 B300.29%
1999-12-31โ‚น0.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Aeterna Zentaris
AEZS
โ‚น2.50 B 213.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น893.20 B 111,647.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.486 T 185,914.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น198.49 B 24,732.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
โ‚น6.97 B 772.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
โ‚น87.97 B 10,906.62%๐Ÿ‡บ๐Ÿ‡ธ USA